Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 5,744 shares at $27.03 ($155K) on 2025-05-13, disclosed to the SEC on 2025-05-15.
Scheduled sale ($155k) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.03 | 2,872 | $78K | 50.0% |
| 2 | $27.03 | 2,872 | $78K | 50.0% |
| Total | $27.03 avg | 5,744 | $155K | 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |